Integrated multidisciplinary approach to hidradenitis suppurativa in clinical practice,.
Adherence
Hidradenitis suppurativa
Multidisciplinary approach
Patient satisfaction
Journal
International journal of women's dermatology
ISSN: 2352-6475
Titre abrégé: Int J Womens Dermatol
Pays: United States
ID NLM: 101654170
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
06
01
2020
revised:
14
02
2020
accepted:
16
02
2020
entrez:
9
7
2020
pubmed:
9
7
2020
medline:
9
7
2020
Statut:
epublish
Résumé
The European hidradenitis suppurativa (HS) guidelines recommend a multidisciplinary approach for patients with HS and management of comorbidities. We aimed to describe the organization of a multidisciplinary HS program and characterize the patient population. We conducted a retrospective study of patients with HS undergoing prospectively defined multidisciplinary work-up including examinations by a dermatologist, plastic surgeon, smoking specialist, and nutritionist in our outpatient unit between October 2015 and January 2017. The study included 49 patients with a sex ratio of 1:1. A total of 73.4% of patients were smokers, 20.4% were overweight, 48.9% were obese, and 30.6% had symptoms of depression. The mean Sartorius score was 30.4 (±17.6). The outcome of plastic surgery consultation was as follows: 16 patients had operations, 5 were excluded based on medical history, 9 refused surgery, and 16 remained undecided. The refusal rates for consulting with the smoking cessation and nutrition specialists were 55.8% and 69.5%, respectively. Twelve patients received antibiotics, 9 received biologics, 9 underwent medico-surgical treatment, 9 underwent surgery, and 10 were lost to follow-up. The mean visual analogue scale score for satisfaction was 8.3 (±1.6; n = 28). An integrated multidisciplinary care model for HS is associated with high patient satisfaction. Adherence to the proposed comorbidity management was higher in female patients and related to empathetic interactions with physicians.
Sections du résumé
BACKGROUND
BACKGROUND
The European hidradenitis suppurativa (HS) guidelines recommend a multidisciplinary approach for patients with HS and management of comorbidities.
OBJECTIVE
OBJECTIVE
We aimed to describe the organization of a multidisciplinary HS program and characterize the patient population.
METHODS
METHODS
We conducted a retrospective study of patients with HS undergoing prospectively defined multidisciplinary work-up including examinations by a dermatologist, plastic surgeon, smoking specialist, and nutritionist in our outpatient unit between October 2015 and January 2017.
RESULTS
RESULTS
The study included 49 patients with a sex ratio of 1:1. A total of 73.4% of patients were smokers, 20.4% were overweight, 48.9% were obese, and 30.6% had symptoms of depression. The mean Sartorius score was 30.4 (±17.6). The outcome of plastic surgery consultation was as follows: 16 patients had operations, 5 were excluded based on medical history, 9 refused surgery, and 16 remained undecided. The refusal rates for consulting with the smoking cessation and nutrition specialists were 55.8% and 69.5%, respectively. Twelve patients received antibiotics, 9 received biologics, 9 underwent medico-surgical treatment, 9 underwent surgery, and 10 were lost to follow-up. The mean visual analogue scale score for satisfaction was 8.3 (±1.6; n = 28).
CONCLUSION
CONCLUSIONS
An integrated multidisciplinary care model for HS is associated with high patient satisfaction. Adherence to the proposed comorbidity management was higher in female patients and related to empathetic interactions with physicians.
Identifiants
pubmed: 32637537
doi: 10.1016/j.ijwd.2020.02.006
pii: S2352-6475(20)30018-6
pmc: PMC7330447
doi:
Types de publication
Journal Article
Langues
eng
Pagination
164-168Informations de copyright
© 2020 The Author(s).
Références
Microsurgery. 2011 Oct;31(7):539-44
pubmed: 21976179
Patient Prefer Adherence. 2009 Nov 03;3:151-60
pubmed: 19936157
Am J Prev Med. 2016 Jun;50(6):709-718
pubmed: 26711162
Med J Aust. 1994 Jul 18;161(2):130-5
pubmed: 8028537
Ann Chir Plast Esthet. 2014 Feb;59(1):29-34
pubmed: 24290491
Ann Plast Surg. 2016 Aug;77(2):217-22
pubmed: 26559649
J Allergy Clin Immunol. 2016 Aug;138(2):325-34
pubmed: 27497275
J Am Acad Dermatol. 2014 Dec;71(6):1144-50
pubmed: 25440440
Dermatology. 1999;198(3):261-4
pubmed: 10393449
Encephale. 1963 Nov-Dec;52:497-504
pubmed: 14094014
Br J Dermatol. 2014 Dec;171(6):1561-5
pubmed: 24842009
Addiction. 1993 Aug;88(8):1127-35
pubmed: 8401167
Br J Dermatol. 1988 Sep;119(3):345-50
pubmed: 3179207
Arch Dermatol Res. 2012 Jan;304(1):7-13
pubmed: 21904925
Addict Behav. 1997 Nov-Dec;22(6):783-7
pubmed: 9426796
J Eur Acad Dermatol Venereol. 2015 Apr;29(4):619-44
pubmed: 25640693
Br J Dermatol. 2009 Oct;161(4):831-9
pubmed: 19438453
Dermatol Clin. 2016 Jan;34(1):69-80
pubmed: 26617360
Rev Mal Respir. 2006 Jun;23(3 Pt 1):227-36
pubmed: 16788523
J Fam Pract. 1992 Jun;34(6):739-44
pubmed: 1593248
Br J Dermatol. 2014 Oct;171(4):819-24
pubmed: 24804604
Ann Dermatol Venereol. 2007 Feb;134(2):173-4
pubmed: 17375017
J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S70-7
pubmed: 26470621
Clin Exp Dermatol. 1994 May;19(3):210-6
pubmed: 8033378
Acta Derm Venereol. 2014 Sep;94(5):553-7
pubmed: 24577555
J Am Acad Dermatol. 2008 Oct;59(4):596-601
pubmed: 18674845
J Am Acad Dermatol. 2010 Apr;62(4):706-8, 708.e1
pubmed: 20227585
PLoS One. 2015 Dec 16;10(12):e0145076
pubmed: 26674526
J Bras Pneumol. 2008 Oct;34(10):845-80
pubmed: 19009219
Actas Dermosifiliogr. 2014 May;105(4):371-7
pubmed: 24360030
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
JAMA Dermatol. 2014 Dec;150(12):1273-80
pubmed: 25229996
Int J Womens Dermatol. 2018 Feb 01;4(2):74-79
pubmed: 30023423
Arch Plast Surg. 2017 May;44(3):228-233
pubmed: 28573098
J Am Acad Dermatol. 2014 Apr;70(4):699-703
pubmed: 24433875
Dermatol Clin. 2016 Jan;34(1):97-109
pubmed: 26617363
Photodiagnosis Photodyn Ther. 2017 Jun;18:46-49
pubmed: 28119142
Br J Dermatol. 2012 Jul;167(1):206-8
pubmed: 22229974